Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R31 | P59538 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GUSB | P08236 | 4/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | XDH | P47989 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19736061 | 0.93 | TAS2R31 (0.54) | TAS2R31MAPTPOLBMEN1GAA | |
| SCHEMBL19033824 | 0.91 | TAS2R31 (0.51) | TAS2R31MAPTPOLBMEN1GAA | |
| SCHEMBL27775946 | 0.90 | IDO1 (0.49) | TAS2R31MAPTPOLBGUSBIDO1 | |
| SCHEMBL4129038 | 0.83 | TAS2R31 (0.57) | TAS2R31MAPTPOLBMEN1GAA | |
| SCHEMBL19736056 | 0.82 | IDO1 (0.51) | TAS2R31MAPTIDO1CYP19A1NPC1 | |
| SCHEMBL782044 | 0.76 | TAS2R31 (0.74) | TAS2R31MAPTPOLBCYP19A1TP53 | |
| SCHEMBL4225984 | 0.76 | TAS2R31 (0.74) | TAS2R31MAPTPOLBCYP19A1TP53 | |
| SCHEMBL16894655 | 0.76 | CYP1A1 (0.60) | TAS2R31MAPTPOLBMEN1GAA | |
| SCHEMBL14421486 | 0.76 | TAS2R31 (0.57) | TAS2R31MAPTPOLBMEN1GAA | |
| SCHEMBL19736058 | 0.74 | ODC1 (0.49) | TAS2R31MAPTPOLBMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170360744-A1 | AGENT CONTAINING FLAVONOID DERIVATIVES FOR TREATING CANCER AND INFLAMMATION | FLAVOCURE BIOTECH INC. | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360744-A1 | AGENT CONTAINING FLAVONOID DERIVATIVES FOR TREATING CANCER AND INFLAMMATION | TNF, NLRP3, F3 | TAS2R31 2271/4885MAPT 1505/4885POLB 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.